Compare ARPA (ARPA) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARPA vs Enzyme — how do they compare? ARPA trades at Rp151.82 (market cap Rp230,77M, Rp89,85M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: ARPA is the larger of the two by market cap, and ARPA's circulating supply is 1,5B ARPA versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold ARPA for 42 Days and Enzyme for 29 Days on average.
| ARPA | MLN | |
|---|---|---|
Market Cap | Rp230,77M | Rp134,13M |
Volume (24h) | Rp89,85M | Rp104,56M |
Circulating Supply | 1,5B ARPA | 3,3M MLN |
Typical Hold Time | 42 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARPA is trading at Rp151.96 with a bearish technical signal, currently near the pivot point of Rp152. Support levels are at Rp149, Rp146, and Rp143, while resistance lies at Rp155, Rp158, and Rp161. The market cap is Rp230.77 million with a hold time of 42 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are available, keeping fundamental developments neutral.
Overall outlook is cautious due to bearish technicals and limited fundamental catalysts. Opportunities include potential rebounds from support zones, but risks involve low liquidity and high volatility. Investors should monitor for any network updates or exchange developments that could impact price action.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ARPA
ARPA Network (ARPA) is a decentralized secure computation network built to improve the fairness, security, and privacy of blockchains. ARPA threshold BLS signature network serves as the infrastructure of verifiable Random Number Generator (RNG), secure wallet, cross-chain bridge and decentralized custody across multiple blockchains. ARPA was previously known as ARPA Chain, a privacy-preserving Multi-party Computation (MPC) network founded in 2018. ARPA Mainnet has completed over 224,000 computation tasks in the past years.
Read more on ARPA →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
